Latest Advisory

  • FDA Advisory No. 2018-049 || Public Health Warning Against the Purchase and Consumption of the Following Unregistered Food Products and Food Supplements:

    FDA Advisory No. 2018-049 || Public Health Warning Against the Purchase and Consumption of the Following Unregistered Food Products and Food Supplements:

    Read more

  • FDA Advisory No. 2018-048 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    FDA Advisory No. 2018-048 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    Read more

  • FDA Advisory No. 2018-047 || ASEAN Advisory Statement on Talc

    FDA Advisory No. 2018-047 || ASEAN Advisory Statement on Talc

    Read more

  • FDA Advisory No. 2018-046 || Public Health Warning Against the Use of Unregistered Medical Device (Mersilk Black Braided Silk Suture N536)

    FDA Advisory No. 2018-046 || Public Health Warning Against the Use of Unregistered Medical Device (Mersilk Black Braided Silk Suture N536)

    Read more

  • FDA Advisory No. 2018-045 || Voluntary Product Recall of Guider Softip Guiding Catheter

    FDA Advisory No. 2018-045 || Voluntary Product Recall of Guider Softip Guiding Catheter

    Read more

  • FDA Advisory No. 2018-044 || VOLUNTARY RECALL OF THE MALECOT NEPHROSTOMY CATHETERS WITH PRODUCT REGISTRATION MDR NO. 02508

    FDA Advisory No. 2018-044 || VOLUNTARY RECALL OF THE MALECOT NEPHROSTOMY CATHETERS WITH PRODUCT REGISTRATION MDR NO. 02508

    Read more

  • FDA Advisory No. 2018-043 || VOLUNTARY RECALL OF INNOVA™ 180 mm & 200 mm SELF-EXPANDING STENT SYSTEM

    FDA Advisory No. 2018-043 || VOLUNTARY RECALL OF INNOVA™ 180 mm & 200 mm SELF-EXPANDING STENT SYSTEM

    Read more

  • FDA Advisory No. 2018-042 || Lifting the Advisory of LIPA YOUNG COCONUT WATER WITH COCONUT BITS under FDA Advisory No. 2016-071, Subject: “Public Health Warning Against the Use of the Following Unregistered Food Product: Lipa Fresh Buko Juice Young Coconu

    FDA Advisory No. 2018-042 || Lifting the Advisory of LIPA YOUNG COCONUT WATER WITH COCONUT BITS under FDA Advisory No. 2016-071, Subject: “Public Health Warning Against the Use of the Following Unregistered Food Product: Lipa Fresh Buko Juice Young Coconu

    Read more

  • FDA Advisory No. 2018-041 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 3)

    FDA Advisory No. 2018-041 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 3)

    Read more

  • FDA Advisory No. 2018-040 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 3)

    FDA Advisory No. 2018-040 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 3)

    Read more

  • FDA Advisory No. 2018-039 || Public Health Warning Against the Use of Cosmetic Products Containing Banned Ingredient/s (Batch 3)

    FDA Advisory No. 2018-039 || Public Health Warning Against the Use of Cosmetic Products Containing Banned Ingredient/s (Batch 3)

    Read more

  • FDA Advisory No. 2018-038 || Public Health Warning Against the Use of Cosmetic Products Containing Banned Ingredient/s (Batch 2)

    FDA Advisory No. 2018-038 || Public Health Warning Against the Use of Cosmetic Products Containing Banned Ingredient/s (Batch 2)

    Read more

  • FDA Advisory No. 2018-037 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 1)

    FDA Advisory No. 2018-037 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 1)

    Read more

  • FDA Advisory No. 2018-036-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na Hair Organics Ocara Hair Grower Hair Vitamins Gugo + Aloe Vera + Minoxidil Shampoo 150 mL.

    FDA Advisory No. 2018-036-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na Hair Organics Ocara Hair Grower Hair Vitamins Gugo + Aloe Vera + Minoxidil Shampoo 150 mL.

    Read more

  • FDA Advisory No. 2018-036 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product Hair Organics Ocara Hair Grower Hair Vitamins Gugo + Aloe Vera + Minoxidil Shampoo 150 mL.

    FDA Advisory No. 2018-036 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product Hair Organics Ocara Hair Grower Hair Vitamins Gugo + Aloe Vera + Minoxidil Shampoo 150 mL.

    Read more

  • FDA Advisory No. 2018-035-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Hindi Rehistradong Gamot:

    FDA Advisory No. 2018-035-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Hindi Rehistradong Gamot:

    Read more

  • FDA Advisory No. 2018-035 || Public Health Warning Against the Purchase and Use of the Following Unregistered  Drug Products:

    FDA Advisory No. 2018-035 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

    Read more

  • FDA Advisory No. 2018-034 || Reiteration of Grace Periods Given to the Cosmetic Industry for Ingredients Banned or Restricted During the Recent ASEAN Cosmetic Committee (ACC) Meetings and Its Related Events

    FDA Advisory No. 2018-034 || Reiteration of Grace Periods Given to the Cosmetic Industry for Ingredients Banned or Restricted During the Recent ASEAN Cosmetic Committee (ACC) Meetings and Its Related Events

    FDA Advisory No. 2018-034

    Reiteration of Grace Periods Given to the Cosmetic Industry for Ingredients Banned or Restricted During the Recent ASEAN Cosmetic Committee (ACC) Meetings and Its Related Events 

    In the interest of public service and in line with the Food and Drug Administration’s (FDA’s) thrust to strengthen its enforcement of existing rules, regulations and standards, the Center for Cosmetics Regulation and Research (CCRR) hereby reiterates the impending end of the grace periods given to the cosmetic industry through FDA Circulars No.  2017-006 and 2017-007 for newly banned ingredients or ingredients with new restrictions adopted during the 25th and 26th ASEAN Cosmetic Committee (ACC) meetings and its related events.

    • FDA Circular No. 2017-006 “Updates and Amendments of the ASEAN Cosmetic Directive as Adopted During the 25th ASEAN Cosmetic Committee Meeting and Its Related Events

    ACD Annex and Reference No.

    Chemical / Substance

    Maximum Authorized Concentration and/or Other Limitations and Requirements

    Grace Period

    Annex III Ref. No. 15d

    Potassium Hydroxide

    1.5% as callosity softener / remover

    Conditions of use and warning which must be printed on the label:

    ·         Contains alkali.

    ·         Avoid contact with eyes

    ·         Keep out of reach of children

    ·         Read directions for use carefully

    31 August 2018

    Annex IV Color Index (CI) 77266

    Carbon Black

    Additional Restriction/Conditions of Use:

    Purity >97 %, with the following impurity profile: Ash content ≤ 0.15%, total sulphur ≤ 0.65%, total PAH ≤500 ppb and benzo(a)pyrene ≤ 5ppb, dibenz(a,h)anthracene ≤5 ppb, total As ≤3 ppm, total Pb ≤10 ppm, total Hg ≤ 1ppm.

    31 August 2018

    Annex IV CI 77266 (nano)

    Carbon Black (Nano)

    10%

    Not to be used in applications that may lead to exposure of the end user's lungs by inhalation.

    Only nanomaterials having the following characteristics are allowed:

    — Purity >97%, with the following impurity profile: Ash content ≤0.15%, total sulphur ≤0.65%, total PAH ≤500 ppb and benzo(a)pyrene ≤5 ppb, dibenz(a,h)anthracene ≤5 ppb, total As ≤3 ppm, total Pb ≤10 ppm, and total Hg ≤1 ppm;

    — Primary particle size ≥20 nm.

    31 August 2018

    Annex VI Ref. No. 57

    2-Methyl-2H-isothiazol- 3-one

     

    Methylisothiazolinone

    0.01%

    Allowed to be used only in rinse-off products.

    Prohibited in leave-on products.

    31 August 2018

    Annex VII Ref. No. A29

    Zinc Oxide

     

    Additional Restriction/Conditions of Use:

    “Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation.”

    31 August 2018

    Annex VII Ref. No. A29a

    Zinc Oxide (nano)

    25%1

    Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation.

    Only nanomaterials having the following characteristics are allowed:

    -          purity ≥96% with wurtzite crystalline structure and physical appearance as clusters that are rod-like, star-like and/or isometric shapes, with impurities consisting only of carbon dioxide and water whilst other impurities are less than 1% in total.

    -          Median diameter of the particle number size distribution D50 (50% of the number below this diameter) >30 nm and D1 (1% below this size) >20nm.

    -          Water solubility <50 mg/l.

    -          Coating materials can be used that have been demonstrated to be safe and not to affect the nanoparticle properties related to the behaviour and/or effects2

    31 August 2018

    Annex VII Ref. No. 27a

    Titanium Dioxide (nano)

    25%3

    Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation.

    Only nanomaterials having the following characteristics are allowed:

    - Purity ≥99%

    - Rutile form, or rutile with up to 5% anatase, with crystalline structure and physical appearance as clusters of spherical, needle, or lanceolate shapes,

    - Median particle size based on number size distribution ≥30 nm,

    - Aspect ratio from 1 to 4.5 and volume specific surface area ≤460 m2/cm3,

    - Coating materials can be used that have been demonstrated to be safe and not to affect the nanoparticle properties related to the behaviour and/or effects4

    - Photocatalytic activity ≤ 10% compared with corresponding non-coated or non-doped reference,

    - Nanoparticles are photostable in the final formulation.

    31 August 2018

     

    1 In case of combined use of Zinc Oxide and Zinc Oxide (nano), the sum shall not exceed the maximum authorized concentration which is 25%.

    2The amendment to the original restriction on the coating material for Zinc Oxide (nano) is adopted during the 26th ACC Meeting and its related events and disseminated through FDA Circular No. 2017-007.

    3 In case of combined use of Titanium Dioxide and Titanium Dioxide (nano), the sum shall not exceed the maximum authorized concentration which is 25%.

    4The amendment to the original restriction on the coating material for Titanium Dioxide (nano) is adopted during the 26th ACC Meeting and its related events and disseminated through FDA Circular No. 2017-007.

    • FDA Circular No. 2017-007 “Updates and Amendments of the ASEAN Cosmetic Directive as Adopted During the 26th ASEAN Cosmetic Committee Meeting (ACC) and Its Related Events

    ACD Annex and Reference No.

    Chemical / Substance

    Maximum Authorized Concentration and/or Other Limitations and Requirements

    Grace Period

    Annex III Ref. No. 312

    Diethylene Glycol Monoethyl Ether (DEGEE)

     

    Ethoxydiglycol

    a.       Oxidative hair dye products – 7%

    b.       Non-oxidative hair dye products – 5%

    c.        Rinse-off products other than hair dye products – 10%

    d.       Other non-spray cosmetic products – 2.6%

    e.        The following spray products: fine fragrances, hair sprays, anti-perspirants and deodorants – 2.6%

     

    (a) to (e) The level of ethylene glycol impurity in Ethoxydiglycol must be ≤0.1 %

    Not to be used in eye products and oral products.

    01 December 2018

    Annex III Ref. No. 313

    Polidocanol

     

    Laureth-9

     

    a.       Leave-on products – 3.0%

    b.       Rinse-off products – 4.0%

    01 December 2018

    Annex III

    Hair Dye Entries

    Additional conditions of use and warning which must be printed on the label:

    Do not use to dye eyelashes or eyebrows

    01 June 2018

    Annex VII Ref. No. 4

    Oxybenzone (INN)

    6%

     

    Conditions of use and warning which must be printed on the label:

    Contains oxybenzone

     

    01 December 2018

    Cosmetic establishments are strongly advised to recall their products containing the abovementioned ingredients whose use is outside the new restrictions and conditions laid down in the ASEAN Cosmetic Ingredient Annexes by the end of the grace period. Violation of the new restrictions and conditions after the grace period has ended shall subject the violator to appropriate regulatory actions.

    For more information, cosmetic establishments may check the FDA website (www.fda.gov.ph) for updates and amendments to the ASEAN Cosmetic Directive (ACD), its annexes and appendices.

    Dissemination of the information to all concerned is requested.

    Read more

  • FDA Advisory No. 2018-033 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    FDA Advisory No. 2018-033 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    Read more

  • FDA Advisory No. 2018-032 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    FDA Advisory No. 2018-032 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    Read more

Date : 20 February 2018

For : All Enrolled Participants of Licensing Seminar for Drugstores and Outlets in General Santos City

Subject : Seminar Venue for the Licensing Seminar for Drugstores and Outlets in General Santos City

Please be informed that the Licensing Seminar for Drugstores and Outlets on 23 February 2018 will be conducted in Greenleaf Hotel, General Santos City.

Venue : Greenleaf Hotel Gensan

Address: San Miguel St. cor J. Catolico Ave., General Santos City

For inquiries and other concerns, please call the FDA Academy at telephone number (202) 877 0259

Date : 12 February 2018

For : All Enrolled Participants of Pharmacovigilance (PV) Regulations and Guidelines for PV Officers

Subject : Change of Seminar date for the COnduct of Pharmacovigilance (PV) Regulations and Guidelines for PV Officers

Please be informed that the conduct of Pharmacovigilance (PV) Regulations and Guidelines for PV Officers on 22-23 March 2018 WILL BE MOVED to 21-21 March 20018. The seminar will be held within Muntinlupa City, NCR, venue to be sent throuogh email to the confirmed participants.

For Inquiries and other concerns, please call the FDA Academy at Telephone number (02) 877 0259.

Date : 06-February-2018

For : All Enrolled Participants to the Licensing Seminar for Drugstores and Outlets

Subject: Reschedule of the Conduct of Licensing Seminar for Drugstores and Outlets (LSDO-NL)

Please be informed that the conduct of the Licensing Seminar for Drugstores and Outlets (LSDO-NL) on 09-February-2018 is POSTPONED and MOVED to 23-March 2018 in Baguio City.

This is due to the conflict with seminar venue and local festival in Baguio City. All paid participants are automatically registered to the rescheduled date of LSDO-NL. Our apologies for the inconvenience this may have caused you.

Date : 12 February 2018

For : All Enrolled Participants of the Licensing Seminar for Drugstores and Outlets

Subject : Change of Venue of the Conduct of Licensing Seminar for Drugstores and Outlets for 09 March 2018

Please be informed that the conduct of Licensing Seminar for Drugstores and Outlets in Legazpi City on 09 March 2018 Will be moved to Naga City, Camarines Sur. This is to ensure the safety of all seminar participants following the unrest volcanic activity of Mt. Mayon in Albay.

For inquiries and other concerns, please call the FDA Academy at Telephone Number (02) 877 0259

Date: 31 January 2018

For : All FDA Clients/Stakeholders

Subject: Alternate e-Mail Address for E-nroll Course Registration of FDA Academy

Please be informed that This email address is being protected from spambots. You need JavaScript enabled to view it. now have an alternate e-mail address of This email address is being protected from spambots. You need JavaScript enabled to view it.. All interested participants of FDA Academy Seminars may use the alternate e-mail if the default e-mail is inaccessible or errors are encountered.

For any concern, please contact FDA Academy at (02) 877-0259. Thank You

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter